Prof Anand Kumar Kondapi
vidwan id: 72121
Professor, Department of Biotechnology
University of Hyderabad
Expertise
- Biotechnology and Applied Microbiology
Publications
Publications
No publication activity to display at the moment.
Scopus
h-index
7
CrossRef
Citations
106
h-index
6
Google Scholar
Loading Scholar statistics...
Professional Recognition
Fellow of Telangana Akademy of Sciences
TSASFellow of AP Akademi Of Sciences
APASBiotechnology Overseas Associateship (LT)
DBTNBTB Research Associateship
DBTDr. K. S. Krishnan DAE Fellowship
DAECommunity & Membership
Review Committee on Genetic Manipulation
MemberExpert Committee on Molecular Diagnostics
Recombinant DNAScientific Advisory Committee
MemberExpert committee on Infectious Diseases Biology
MemberAmerican Association of Phamaceutical Scienstists
Indian Science Congress
Indian Neuroscience Society.
Association of DNA finger printing and other DNA technologies
Indian Society for Technical Education
Bio
Molecular therapeutics, HIV, Cancer, Brain ageing
Personal Details
- Male
- Professor , University of Hyderabad
- University of Hyderabad, Prof CR Rao Road, Gachibowli
Related Profiles
Experts (1764+)
View All
Assistant Professor
Assistant Professor
Assistant Professor
Physical Director
Assistant Professor
Assistant Professor
Dr Jyothi Alias Jyotsna Baragi
Assistant Professor
Assistant Professor
Professor
N/A
Organisations (383+)
View All
Professor
Senior Professor
Professor
Assistant Professor
Assistant Professor
Librarian
Dr Bapuji Ramamohana Bhaskaramma
Professor
Associate Professor
Senior Professor
Assistant Professor
Co-Authors (16)
Birla Institute of Technology and Science
CSIR-Indian Institute of Chemical Technology
Indian Institute of Petroleum & Energy
Central University of Himachal Pradesh
Maulana Azad National Urdu University
University of Hyderabad
University of Hyderabad
Nagaland University
Mepco Schlenk Engineering College, Virudhunagar
Indian Institute of Technology Mandi
University of Hyderabad
Prof Ravindranath Singh Rathore
Central University of South Bihar
University of Hyderabad
University of Hyderabad
University of Hyderabad
Indian Institute of Science Bangalore
Scholarly Work
Design and Synthesis of a new class of anti-cancer metal Complexes with topoisomerase II as a potential target.
Funding Agency: CSIR
647,000
-0001 - Ongoing
Isolation
Funding Agency: 1600000
Complete
-0001 - Ongoing
An analysis on topoisomerase II activation during HIV infection: Characterization of Topoisomerase II activation in primary events of HIV infection
Funding Agency: Department of Science and Technology, Govt. of India
1,710,000
-0001 - Ongoing
Characterization of anti-HIV activities of early pregnancy associate protein 1 in vitro.
Funding Agency: DBT
2,800,000
-0001 - Ongoing
Development of novel anti-HIV molecules based on through characterization of mechanism of action of Topoisomerase II inhibitors during HIV replication.
Funding Agency: Department of Science and Technology, Govt. of India
1,800,000
-0001 - Ongoing
Supported Advanced Center for Research in Ageing Brain; Correlation of Topoisomerase II alpha and beta activities in ageing brain.
Funding Agency: ICMR
11,000,000
-0001 - Ongoing
Development and targeted-delivery of Topoisomerase II isoform specific poisons and Evaluation of drug efficacy in rat cancer model.
Funding Agency: DBT
2,500,000
-0001 - Ongoing
A study of HIV-1 envelope induced neurotoxicity in rat cerebellar neurons and astrocytes: Identification of non-neurotoxic HIV Vaccine candidates.
Funding Agency: ILS-UH
490,000
-0001 - Ongoing
A monitoring and analysis of anti-HIV active early pregnancy associated proteins 1 & 2 in pregnant women.
Funding Agency: ICMR
1,000,000
-0001 - Ongoing
Characterization of HIV-associated Topoisomerase II associated kinase activities.
Funding Agency: Department of Science and Technology, Govt. of India
1,800,000
-0001 - Ongoing
Characterization of HIV-associated Topoisomerase II associated kinase activities.
Funding Agency: ICMR-Indo US Joint statement
2,800,000
-0001 - Ongoing
Characterization of DNA repair and recombination activities of Topoisomerase II and novel polymerases in primary neurons.
Funding Agency: Department of Science and Technology, Govt. of India
1,800,000
-0001 - Ongoing
Neuro-immune interactions in aging and immunodeficiency.
Funding Agency: ICMR
3,000,000
-0001 - Ongoing
Characterization of anti-HIV properties of peptides derived from Epap-1.
Funding Agency: DBT
8,800,000
-0001 - Ongoing
Characterization of Topoisomerase II beta associated senescence mechanisms in neurons in vitro and in vivo.
Funding Agency: DBT
4,600,000
-0001 - Ongoing
Development of patentable HIV inhibitors targeted to HIV-1 associated Topoisomerase II beta kinase
Funding Agency: Department of Science and Technology, Govt. of India
4,100,000
-0001 - Ongoing
Development of protein nanoparticles based microbicidal formulation in combination of curcumin and antiretroviral agent (NanoCurcARV)
Funding Agency: DBT-ICMR
6,000,000
-0001 - Ongoing
Development of targeted
Funding Agency: 5200000
Complete
-0001 - Ongoing
Molecular Characterization of function of Topoisomerase II alpha and beta during HIV-1 reverse transcription in early replication
Funding Agency: Department of Science and Technology, Govt. of India
500,000
-0001 - Ongoing
Curcumin: A multi mechnism HIV microbicide
Funding Agency: ICMR Indo-US
4,600,000
-0001 - Ongoing
Characterization of Epap-1 bound epitopes of gp120: Development of novel entry inhibitors
Funding Agency: DBT
6,600,000
-0001 - Ongoing
Screening and mechanism of action of anti-HIV molecules
Funding Agency: Dr Reddy's Research Foundation
1,100,000
-0001 - Ongoing
Evaluation of potency of the multiherbal preparation
Funding Agency: Envin Bioceuticals
50,000
-0001 - Ongoing
Screening and analysis of HIV-1 protease inhibitors
Funding Agency: Hetero Drugs Ltd.
5,500,000
-0001 - Ongoing
Screening Anti-HIV activity of Molecules
Funding Agency: Arabindo Research Centre
600,000
-0001 - Ongoing
Screening and analysis of HIV-1 inhibitors
Funding Agency: Hetero Drugs Ltd.
1,000,000
-0001 - Ongoing
Nanoformulation development
Funding Agency: V Life Technologies
25,000
-0001 - Ongoing
Anti-HIV-1 screening
Funding Agency: AJ Orgnica Ltd
100,000
-0001 - Ongoing
Pharmacological evaluation of Nanoofrmulation
Funding Agency: Aizant
240,000
-0001 - Ongoing
Design and synthesis of anticancer cobalt complexes: Molecular mechanism of action on Topoisomerase II
A novel class of Topoisomerase II poisons containing iron and ruthenium: anticancer activity and targeted delivery
Analysis and mechanism of action of anti-HIV active glycoprotein present during early pregnancy
A study on the age dependent changes of Topoisomerase II alpha and Topoisomerase II beta isoforms in rat brain and sensitivity of Topoisomerase II isoforms to Topo II poisons
Identification and characterization of Topoisomerase II alpha and beta kinase activity in HIV-1 infected cells and virus particles
Cloning and expression of Epap-1 in Sf 9 cells and characterization of its anti-viral activities
Isolation and characterization of Placental Epap-1 secreting endothelial cells and an analysis of anti-viral activity of recombinant Epap-1
Molecular mechanism of DNA Topoisomerase II isoforms in HIV-1 early replication
Characterization of Topoisomerase II activities in neuronal development
Design
A study on DNA Topoisomerases during neuronal aging in vitro and in vivo
HIV-associated Topoisomerase II? kinase: Purification
Design and Development of Epap-1 derived anti-HIV-1 peptides
Characterization of TopoisomeraseII?-associated Base excision repair and Senescence in Cultured cerebellar granule neurons
Doxorubicin nanoformulations of apotransferrin and lactoferrin: Bioavailability
HIV-1 Reverse Transcription: Role of Topoisomerase II isoforms and Topoisomerase II? kinase
Regulatory activities of topoisomerase II beta in DNA repair
Characterization of anti HIV-1 activity of curcumin and its analogues and their delivery by apotransferrin nanoparticles
Long term non-progressors of HIV-1 perinatally infected children: Vila Genetic and Immunological profile.
Characterization of Ventral Mesencephalic neuron enriched culture in vitro: Correlation to Parkinson
Development of Carboplatin
Antiretroviral Drug loaded Lactoferrin nanoparticle formulation for oral delivery: Improved Efficacy
Analysis of gene interaction networks in neuronal aging and HIV infection
Development of efficient and safe lactoferrin nanoparticles based MPT Microbicidal Drug delivery systems against HIV-1
Lactoferrin nanoparticles for tageted tumor therapy: Implications in blioblastoma and melanoma management
Design
No Data Found
There is currently nothing to display here.
